C202-2605 Screening compound: 3-(4-ethoxyphenyl)-6-(2,3,4-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

C202-2605 Screening compound: 3-(4-ethoxyphenyl)-6-(2,3,4-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
C202-2605 Screening compound: 3-(4-ethoxyphenyl)-6-(2,3,4-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound C202-2605
3-(4-ethoxyphenyl)-6-(2,3,4-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C202-2605

Molecular Formula

C24H23N3O6 (C24 H23 N3 O6)

Compound Name

3-(4-ethoxyphenyl)-6-(2,3,4-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

IUPAC name

3-(4-ethoxyphenyl)-6-(234-trimethoxyphenyl)-1H-pyrazolo[34-b]pyridine-4-carboxylic acid

SMILES

CCOc(cc1)ccc1-c1n[nH]c2nc(-c(ccc(OC)c3OC)c3OC)cc(C(O)=O)c12

InChI

InChI=1S/C24H23N3O6/c1-5-33-14-8-6-13(7-9-14)20-19-16(24(28)29)12-17(25-23(19)27-26-20)15-10-11-18(30-2)22(32-4)21(15)31-3/h6-12H,5H2,1-4H3,(H,28,29)(H,25,26,27)

InChI Key

CHWOGYXYBGLMNJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14731131

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.46

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.567

Distribution Coefficient, logD

-0.268

Water Solubility, LogSw

-4.48

Polar Surface Area

91.480

Acid Dissociation Constant (pKa)

3.16

Base Dissociation Constant (pKb)

3.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

C202-2605 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with C202-2605 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C202-2605?
Check Price and Availability of C202-2605, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C202-2605 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C202-2605
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C202-2605
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C202-2605 available by request